{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:09:29Z","timestamp":1791461369862,"version":"4.3.4"},"reference-count":35,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2019,6,29]],"date-time":"2019-06-29T00:00:00Z","timestamp":1561766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Esophageal squamous cell carcinoma (ESCC) is the most common primary esophageal malignancy. Telmisartan, an angiotensin II type 1 (AT1) receptor blocker (ARB) and a widely used antihypertensive, has been shown to inhibit proliferation of various cancer types. This study evaluated the effects of telmisartan on human ESCC cell proliferation in vitro and in vivo and sought to identify the microRNAs (miRNAs) involved in these antitumor effects. We examined the effects of telmisartan on three human ESCC cell lines (KYSE150, KYSE180, and KYSE850). Telmisartan inhibited proliferation of these three cell lines by inducing S-phase arrest, which was accompanied by decreased expression of cyclin A2, cyclin-dependent kinase 2, and other cell cycle-related proteins. Additionally, telmisartan reduced levels of phosphorylated ErbB3 and thrombospondin-1 in KYSE180 cells. Furthermore, expression of miRNAs was remarkably altered by telmisartan in vitro. Telmisartan also inhibited tumor growth in vivo in a xenograft mouse model. In conclusion, telmisartan inhibited cell proliferation and tumor growth in ESCC cells by inducing cell-cycle arrest.<\/jats:p>","DOI":"10.3390\/ijms20133197","type":"journal-article","created":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T03:23:59Z","timestamp":1561951439000},"page":"3197","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Telmisartan Inhibits Cell Proliferation and Tumor Growth of Esophageal Squamous Cell Carcinoma by Inducing S-Phase Arrest In Vitro and In Vivo"],"prefix":"10.3390","volume":"20","author":[{"given":"Takanori","family":"Matsui","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Neurology, Kagawa University, Kagawa 761-0793, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiga","family":"Chiyo","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Neurology, Kagawa University, Kagawa 761-0793, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Kobara","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Neurology, Kagawa University, Kagawa 761-0793, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Fujihara","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Neurology, Kagawa University, Kagawa 761-0793, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9390-7565","authenticated-orcid":false,"given":"Koji","family":"Fujita","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Neurology, Kagawa University, Kagawa 761-0793, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Namima","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Neurology, Kagawa University, Kagawa 761-0793, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Nakahara","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Neurology, Kagawa University, Kagawa 761-0793, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuya","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Neurology, Kagawa University, Kagawa 761-0793, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Nishiyama","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Neurology, Kagawa University, Kagawa 761-0793, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuo","family":"Yachida","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Neurology, Kagawa University, Kagawa 761-0793, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0760-3045","authenticated-orcid":false,"given":"Asahiro","family":"Morishita","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Neurology, Kagawa University, Kagawa 761-0793, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisakazu","family":"Iwama","sequence":"additional","affiliation":[{"name":"Life Science Research Center, Kagawa University, Kagawa 761-0793, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Masaki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Neurology, Kagawa University, Kagawa 761-0793, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,6,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA A Cancer J. Clin."},{"key":"ref_2","unstructured":"World Cancer Research Fund International (2019, June 10). Oesophageal Cancer Report 2016. Available online: http:\/\/www.wcrf.org\/dietandcancer\/oesophageal-cancer."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"17048","DOI":"10.1038\/nrdp.2017.48","article-title":"Cunningham, D. Oesophageal cancer","volume":"3","author":"Smyth","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0140-6736(12)60643-6","article-title":"Oesophageal carcinoma","volume":"381","author":"Pennathur","year":"2013","journal-title":"Lancet"},{"key":"ref_5","first-page":"1781","article-title":"Determination of the prognostic significance of unscheduled cyclin A overexpression in patients with esophageal squamous cell carcinoma","volume":"2","author":"Furihata","year":"1996","journal-title":"Clin. Cancer Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3892\/ol.2012.814","article-title":"Cyclin A overexpression is associated with chemosensitivity to paclitaxel-based chemotherapy in patients with esophageal squamous cell carcinoma","volume":"4","author":"Huang","year":"2012","journal-title":"Oncol. Lett."},{"key":"ref_7","first-page":"22","article-title":"Esophageal Cancer","volume":"95","author":"Short","year":"2017","journal-title":"Am. Fam. Phys."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.3892\/ijo_00000776","article-title":"Angiotensin II induces tumor progression and fibrosis in intrahepatic cholangiocarcinoma through an interaction with hepatic stellate cells","volume":"37","author":"Okamoto","year":"2010","journal-title":"Int. J. Oncol."},{"key":"ref_9","first-page":"1893","article-title":"Angiotensin II receptor type 1 blockers suppress the cell proliferation effects of angiotensin II in breast cancer cells by inhibiting AT1R signaling","volume":"27","author":"Du","year":"2012","journal-title":"Oncol. Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.3892\/ijo_00000287","article-title":"Local angiotensin II-generation in human gastric cancer: Correlation with tumor progression through the activation of ERK1\/2, NF-\u03baB and survivin","volume":"34","author":"Kinoshita","year":"2009","journal-title":"Int. J. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1177\/1470320314535275","article-title":"Prognostic impact of renin-angiotensin system blockade in esophageal squamous cell carcinoma","volume":"16","author":"Chen","year":"2015","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.3390\/molecules19032862","article-title":"Telmisartan Exerts Anti-Tumor Effects by Activating Peroxisome Proliferator-Activated Receptor-\u03b3 in Human Lung Adenocarcinoma A549 Cells","volume":"19","author":"Li","year":"2014","journal-title":"Molecules"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Koyama, N., Nishida, Y., Ishii, T., Yoshida, T., Furukawa, Y., and Narahara, H. (2014). Telmisartan Induces Growth Inhibition, DNA Double-Strand Breaks and Apoptosis in Human Endometrial Cancer Cells. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0093050"},{"key":"ref_14","first-page":"295","article-title":"Telmisartan is a potent target for prevention and treatment in human prostate cancer","volume":"20","author":"Funao","year":"2008","journal-title":"Oncol. Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3892\/etm_00000046","article-title":"Telmisartan inhibits human urological cancer cell growth through early apoptosis","volume":"1","author":"Matsuyama","year":"2010","journal-title":"Exp. Ther. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.3892\/or.2017.5977","article-title":"Telmisartan inhibits hepatocellular carcinoma cell proliferation in vitro by inducing cell cycle arrest","volume":"38","author":"Oura","year":"2017","journal-title":"Oncol. Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.3892\/ijo.2017.4177","article-title":"Angiotensin receptor blocker telmisartan inhibits cell proliferation and tumor growth of cholangiocarcinoma through cell cycle arrest","volume":"51","author":"Samukawa","year":"2017","journal-title":"Int. J. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/2211-5463.12055","article-title":"Angiotensin II type 1 receptor blocker telmisartan induces apoptosis and autophagy in adult T-cell leukemia cells","volume":"6","author":"Kozako","year":"2016","journal-title":"FEBS Open Bio"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"8536","DOI":"10.18632\/oncotarget.14345","article-title":"The angiotensin II type 1 receptor antagonist telmisartan inhibits cell proliferation and tumor growth of esophageal adenocarcinoma via the AMPK\u03b1\/mTOR pathway in vitro and in vivo","volume":"8","author":"Fujihara","year":"2017","journal-title":"Oncotarget"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3892\/mmr.2015.4512","article-title":"Telmisartan prevents proliferation and promotes apoptosis of human ovarian cancer cells through upregulating PPAR\u03b3 and downregulating MMP\u20119 expression","volume":"13","author":"Pu","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"ref_21","first-page":"545","article-title":"Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia","volume":"147","year":"1995","journal-title":"Am. J. Pathol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0092-8674(94)90543-6","article-title":"Cyclins and cancer","volume":"79","author":"Hunter","year":"1994","journal-title":"Cell"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0955-2235(91)90004-N","article-title":"Cyclin A, cell cycle control and oncogenesis","volume":"3","author":"Pagano","year":"1991","journal-title":"Prog. Growth Factor Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1053\/jhep.2003.50112","article-title":"Cyclins and cyclin-dependent kinases: Comparative study of hepatocellular carcinoma versus cirrhosis","volume":"37","author":"Masaki","year":"2003","journal-title":"Hepatology"},{"key":"ref_25","first-page":"5859","article-title":"Telmisartan inhibits NSCLC A549 cell proliferation and migration by regulating the PI3K\/AKT signaling pathway","volume":"15","author":"Zhang","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.3892\/ol.2014.2592","article-title":"Antiproliferative and apoptotic effects of telmisartan in human colon cancer cells","volume":"8","author":"Lee","year":"2014","journal-title":"Oncol. Lett."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/cgt.2008.15","article-title":"The ERBB3 receptor in cancer and cancer gene therapy","volume":"15","author":"Sithanandam","year":"2008","journal-title":"Cancer Gene Ther."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1158\/1078-0432.CCR-11-1186","article-title":"Toward the prognostic significance and therapeutic potential of HER3 receptor tyrosine kinase in human colon cancer","volume":"18","author":"Beji","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"5138","DOI":"10.18632\/oncotarget.2094","article-title":"ERBB3 knockdown induces cell cycle arrest and activation of Bak and Bax-dependent apoptosis in colon cancer cells","volume":"5","author":"Lee","year":"2014","journal-title":"Oncotarget"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Zhou, Z.Q., Cao, W.H., Xie, J.J., Lin, J., Shen, Z.Y., Zhang, Q.Y., Shen, J.H., Xu, L.Y., and Li, E.M. (2009). Expression and prognostic significance of THBS1, Cyr61 and CTGF in esophageal squamous cell carcinoma. BMC Cancer, 9.","DOI":"10.1186\/1471-2407-9-291"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1158\/1078-0432.CCR-16-1520","article-title":"Dysregulation of Rab37-mediated cross-talk between cancer cells and endothelial cells via thrombospondin-1 promotes tumor neovasculature and metastasis","volume":"23","author":"Tzeng","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/hepr.12386","article-title":"MiRNA in hepatocellular carcinoma","volume":"45","author":"Morishita","year":"2015","journal-title":"Hepatol. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.7150\/jca.18680","article-title":"MicroRNA-765 Enhances the Anti-Angiogenic Effect of CDDP via APE1 in Osteosarcoma","volume":"8","author":"Liang","year":"2017","journal-title":"J. Cancer"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"6445","DOI":"10.3892\/mmr.2015.4326","article-title":"Epithelial membrane protein 3 functions as an oncogene and is regulated by microRNA-765 in primary breast carcinoma","volume":"12","author":"Hong","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1016\/S0959-8049(03)00490-8","article-title":"The combination of yondelis and cisplatin is synergistic against human tumor xenografts","volume":"39","author":"Colombo","year":"2003","journal-title":"Eur. J. Cancer"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/13\/3197\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:02:23Z","timestamp":1760187743000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/13\/3197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,29]]},"references-count":35,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2019,7]]}},"alternative-id":["ijms20133197"],"URL":"https:\/\/doi.org\/10.3390\/ijms20133197","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,29]]}}}